NorthX Biologics is proud to have the opportunity to support and be a part of AdBIOPRO. “It is a great infrastructure for ground breaking research and development aimed at finding solutions to some of the manufacturing challenges that need a resolution in order to bring advanced therapies to the patients at an affordable cost,” says Ola Tuvesson CTO at NorthX Biologics and member of the AdBIOPRO Centre Board.
Link to the press release: https://www.kth.se/adbiopro/news/adbiopro-competence-centre-for-advanced-bioproduction-secures-112-mkr-funding-1.1252385
NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.
For more news, follow us on LinkedIn
Janet Hoogstraate on Sweden’s role in global biomanufacturing Sweden has built a strong foundation in life science, with world-class research environments, advanced infrastructure, and skilled professionals. In a recent interview ...
Amarna Therapeutics, a privately held biotechnology company pioneering transformative gene therapies, today announced the formalization of an agreement with NorthX Biologics, a leading biologics manufacturing partner, to accelerate the development ...
NorthX Biologics, a leading Nordic biopharmaceutical Contract, Development, and Manufacturing Organization (CDMO), is pleased to announce a significant growth investment from Signet Healthcare Partners (Signet), a U.S.-based healthcare private equity ...